Related Experiment Video
Updated: Jul 16, 2025
10:12
High-throughput DNA Extraction and Genotyping of 3dpf Zebrafish Larvae by Fin Clipping
Published on: June 29, 2018
14.1K
The zebrafish for preclinical psilocybin research
Omer A Syed1, Benjamin Tsang2, Robert Gerlai3
1Department of Biology, University of Toronto Mississauga, Canada.
Neuroscience and Biobehavioral Reviews
|September 9, 2023
Summary
Zebrafish show promise for studying psilocybin, a psychedelic drug, in preclinical research. This review explores their use in assessing anxiety, social behavior, and treatment efficacy for affective disorders.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Psilocybin, a psychedelic compound, is gaining interest for both recreational and potential clinical uses.
- Research into psilocybin's effects and therapeutic applications is expanding.
- Zebrafish offer a unique model organism for preclinical drug research.
Purpose of the Study:
- To review the utility of zebrafish in psilocybin research.
- To explore behavioral assays relevant to psilocybin's effects.
- To discuss genetic manipulation techniques and safety profiles for psilocybin studies in zebrafish.
Main Methods:
- Review of existing literature on zebrafish behavioral tests (anxiety, social behavior).
- Examination of genetic manipulation techniques applicable to psilocybin research.
- Analysis of psilocybin's known mechanisms, safety, and toxicity.
Main Results:
- Zebrafish behavioral assays are relevant for studying psilocybin's impact.
- Genetic tools can be used to investigate psilocybin's mechanisms and effects.
- Psilocybin's safety and toxicity profiles are being characterized.
Conclusions:
- Zebrafish present a valuable model for preclinical psilocybin research.
- The zebrafish model can aid in testing treatment efficacy for affective disorders.
- Further research utilizing zebrafish for psychedelic drug studies is warranted.
